Copyright
©2010 Baishideng.
World J Gastroenterol. Jul 21, 2010; 16(27): 3437-3444
Published online Jul 21, 2010. doi: 10.3748/wjg.v16.i27.3437
Published online Jul 21, 2010. doi: 10.3748/wjg.v16.i27.3437
Figure 1 Comparison of the progression-free survival rates (A) and overall survival (B) between the DDPH and ADM groups.
A: The progression-free survival rate was significantly higher in the DDPH group than in the ADM group (log-rank test: P < 0.001); B: The overall survival was significantly longer in the DDPH group than in the ADM group (log-rank test: P = 0.002). DDPH group: Using a suspension of DDPH in lipiodol (LPD); ADM group: With an emulsion of doxorubicin (ADM) with LPD.
- Citation: Kasai K, Ushio A, Sawara K, Miyamoto Y, Kasai Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K. Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma. World J Gastroenterol 2010; 16(27): 3437-3444
- URL: https://www.wjgnet.com/1007-9327/full/v16/i27/3437.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i27.3437